Tue, February 14, 2012
Mon, February 13, 2012
Sun, February 12, 2012
Fri, February 10, 2012
Thu, February 9, 2012
Wed, February 8, 2012
[ Wed, Feb 08th 2012 ] - Market Wire
Imaging3 Updates Website
Tue, February 7, 2012
Mon, February 6, 2012
Sun, February 5, 2012
[ Sun, Feb 05th 2012 ] - Market Wire
30 a.m. ET
Sat, February 4, 2012
Fri, February 3, 2012
Thu, February 2, 2012
Wed, February 1, 2012

Telik Announces Presentation and Webcast at 14th Annual BIO CEO & Investor Conference


//health-fitness.news-articles.net/content/2012/ .. -at-14th-annual-bio-ceo-investor-conference.html
Published in Health and Fitness on Wednesday, February 8th 2012 at 6:13 GMT by Market Wire   Print publication without navigation


Telik Announces Presentation and Webcast at 14th Annual BIO CEO &... -- PALO ALTO, Calif., Feb. 8, 2012 /PRNewswire/ --

Telik Announces Presentation and Webcast at 14th Annual BIO CEO & Investor Conference

[ ]

PALO ALTO, Calif., Feb. 8, 2012 /PRNewswire/ -- Telik, Inc. (Nasdaq: [ TELK ]) today announced that CEO Michael M. Wick, M.D., Ph.D. will provide a corporate overview at the 14th Annual BIO CEO& Investor Conference in New York City on Tuesday, February 14 at 1:00 p.m. Eastern time (10:00 a.m. Pacific time), in the Waldorf-Astoria Hotel's Conrad Suite.  A live and archived webcast of the presentation will be available on the Telik website, [ www.telik.com ].  The archived broadcast of the presentation can be accessed for 30 days following the presentation.

About Telik

Telik, Inc. of Palo Alto, CA, is a clinical stage drug development company focused on discovering and developing small molecule drugs to treat cancer.  The company's most advanced drug candidate is Telintra®, a modified glutathione analog intended for the treatment of hematologic malignancies including myelodysplastic syndrome; followed by Telcyta®, a cancer activated prodrug for the treatment of a variety of cancers. Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP®, which enables the rapid and efficient discovery of small molecule drug candidates.

Telik, the Telik logo, TELINTRA, TELCYTA and TRAP are trademarks or registered trademarks of Telik, Inc.

SOURCE Telik, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.telik.com ]


Publication Contributing Sources